We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image: Researchers found that combining two Alzheimer’s tests—a p-tau217 blood test and APOE genotyping—can predict symptom onset in people who are not yet experiencing symptoms (Image Credit: Adobe Stock)

Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset

A combined blood-based Alzheimer’s marker and genetic risk test estimates time to symptom onset within 3–6 years in asymptomatic adults. More...
14 Sep 2026
Image: Blood protein levels can reveal whether genetic variants have biological effects, potentially offering a more scalable, noninvasive way to obtain additional patient information (Image Credit: 123RF)

Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants

A new blood proteomics–genomics approach improves interpretation of uncertain variants and supports rare disease diagnosis. More...
12 Sep 2026
Image: DecisionDx-SCC evaluates expression of 40 tumor genes and integrates those data with five clinicopathologic risk factors for high-risk cutaneous squamous cell carcinoma (Image Credit: 123RF)

40-Gene Test Validated for High-Risk Squamous Cell Carcinoma

An integrated 40‑gene expression test improves prognostic accuracy and guides adjuvant radiation in high‑risk cSCC. More...
10 Sep 2026
Image: New findings identify common genetic variants are associated with faster motor decline in Parkinson’s disease (Image Credit: 123RF)

Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease

Researchers identify common genetic variants as markers of faster motor decline in Parkinson’s disease. More...
10 Sep 2026
Image: Prostate Dx, known as the Prostate Specific Biomarker (PSB), blood test is a blood-based molecular diagnostic intended to close the diagnostic gap between an elevated prostate-specific antigen and surgical biopsy (Photo courtesy of 5Q Spectra)

Blood Test Helps Clarify Prostate Cancer Risk After Elevated PSA

A new blood test refines prostate cancer detection after elevated PSA, showing 95% sensitivity and reducing unnecessary biopsies. More...
10 Sep 2026
Image: Could-enabled portable qPCR device from Anitoa (Photo courtesy of Anitoa)

Secure Cloud-Connected qPCR System Enables Remote Infectious Disease Surveillance

Anitoa Systems has added comprehensive cloud connectivity and enterprise-grade security to its portable qPCR instruments.  More...
10 Sep 2026
Image: In the Fetal Extracellular Vesicle Monitoring of Oxygenation (FEMOx) project several of the Wyss Institute’s Technology Platforms and faculty labs join forces. Leveraging and integrating multiple of the Wyss Institute’s technological innovations and advanced analytical capabilities they aim develop a test that can rapidly and accurately detect fetal oxygen deprivation by detecting specific miRNA signatures in extracellular vesicles (EVs) that circulate in maternal blood. (Iimage Credit: Wyss Institute at Harvard University)

Project to Develop Maternal Blood Test for Rapid Fetal Oxygen Deprivation Detection

Researchers are developing a noninvasive blood test that quantifies placental microRNAs to track fetal oxygenation during labor. More...
09 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
New
Automated Immunoassay Analyzer
SuperFlex™


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.